澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide -

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - leflunomide -

美国 - 英文 - NLM (National Library of Medicine)

alembic pharmaceuticals inc. - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide 10 mg - leflunomide tablets usp are indicated for the treatment of adults with active rheumatoid arthritis (ra).  leflunomide is contraindicated in: ·            pregnant women. leflunomide may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1)].   ·            patients with severe hepatic impairment [see warnings and precautions (5.2)]. ·            patients with known hypersensitivity to leflunomide or any of the other components of leflunomide. known reactions include anaphylaxis [see adverse reactions (6.1)]. ·             patients being treated with teriflunomide [see drug interactions (7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy. health care providers and patients are encouraged to report pr

美国 - 英文 - NLM (National Library of Medicine)

alembic pharmaceuticals limited - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide 10 mg - leflunomide tablets usp are indicated for the treatment of adults with active rheumatoid arthritis (ra).  leflunomide is contraindicated in: ·            pregnant women. leflunomide may cause fetal harm. if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1 and 5.3) and use in specific populations (8.1)].   ·            patients with severe hepatic impairment [see warnings and precautions (5.2)]. ·            patients with known hypersensitivity to leflunomide or any of the other components of leflunomide. known reactions include anaphylaxis [see adverse reactions (6.1)]. ·             patients being treated with teriflunomide [see drug interactions (7)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy. health care providers and patients are encouraged to report pr

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

美国 - 英文 - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - leflunomide (unii: g162gk9u4w) (leflunomide - unii:g162gk9u4w) - leflunomide 10 mg - leflunomide tablets, usp are indicated for the treatment of adults with active rheumatoid arthritis (ra). leflunomide tablets are contraindicated in: •pregnant women.  leflunomide may cause fetal harm.  if a woman becomes pregnant while taking this drug, stop leflunomide, apprise the patient of the potential hazard to the fetus, and begin a drug elimination procedure [see warnings and precautions (5.1and 5.3) and use in specific populations (8.1)]. •patients with severe hepatic impairment [see warnings and precautions (5.2)] . •patients with known hypersensitivity to leflunomide or any of the other components of leflunomide tablets. known reactions include anaphylaxis [see adverse reactions (6.1)] . •patients being treated with teriflunomide [see drug interactions (7)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to leflunomide during pregnancy.  health care providers and patients are encouraged to report pregnancies by calling 1-877-3

澳大利亚 - 英文 - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - leflunomide -

加拿大 - 英文 - Health Canada

apotex inc - leflunomide - tablet - 10mg - leflunomide 10mg - disease-modifying antirheumatic agents

加拿大 - 英文 - Health Canada

pro doc limitee - leflunomide - tablet - 20mg - leflunomide 20mg - disease-modifying antirheumatic agents